- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Food Addiction.
Displaying page 1 of 1.
EudraCT Number: 2021-000472-11 | Sponsor Protocol Number: P20-08/BP1.4979 | Start Date*: 2021-11-30 | |||||||||||
Sponsor Name:BIOPROJET PHARMA | |||||||||||||
Full Title: A double-blind, placebo-controlled pilot trial of BP1.4979 for the treatment of binge eating disorder | |||||||||||||
Medical condition: Binge eating disorder (BED) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007020-18 | Sponsor Protocol Number: 1999/07 | Start Date*: 2008-05-26 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Efficacy of baclofen in the treatment of nicotine addicted patients:randomized, double blind study of Baclofen versus placebo | |||||||||||||
Medical condition: Smoking addiction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002408-42 | Sponsor Protocol Number: RB-UK-12-0004 | Start Date*: 2012-11-29 | |||||||||||
Sponsor Name:Reckitt Benckiser Pharmaceuticals Inc. | |||||||||||||
Full Title: An Open-label, Randomised, Three -Way, Cross-Over Study to Assess the Pharmacokinetics, Safety and Tolerability of Two Formulations of RBP-6300 10mg in Healthy Volunteers under a Naltrexone Block i... | |||||||||||||
Medical condition: Maintenance/substitution agent for the treatment of opioid dependence. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000660-33 | Sponsor Protocol Number: ZAF-312 | Start Date*: 2015-09-30 | |||||||||||
Sponsor Name:Zafgen Inc. | |||||||||||||
Full Title: Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of Beloranib in Obese Subjects with Prader-Willi Syndrome to Evaluate Food-related Behavior, Total Body Weight, and Safety Over 52 Weeks | |||||||||||||
Medical condition: Improvement of Hyperphagia and related behaviors as well as Body Composition/Overweight in Prader-Willi-Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) ES (Prematurely Ended) BE (Prematurely Ended) FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004374-22 | Sponsor Protocol Number: 2020-09-HISTORI | Start Date*: 2020-12-16 | |||||||||||||||||||||
Sponsor Name:Steno Diabetes Center Odense | |||||||||||||||||||||||
Full Title: HISTORI Home-based Intervention with Semaglutide Treatment Of Neuroleptica-Related Prediabetes The effect of Semaglutide on diabetes incidence and prevention in patients with in neuroleptica-relat... | |||||||||||||||||||||||
Medical condition: Prediabetes and metabolic syndrome in SGA(second generation of antipshychotic treatment)-treated young adults with schizophrenia. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.